SC-13G

Company

Protara Therapeutics, Inc.

Filed

November 6, 2018

Accession Number

0001193125-18-319652

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →